Cargando…
High expression of GEM and EDNRA is associated with metastasis and poor outcome in patients with advanced bladder cancer
BACKGROUND: The standard treatment for non-metastatic muscle-invasive bladder cancer (stages T2–T4a) is radical cystectomy with lymphadenectomy. However, patients undergoing cystectomy show metastatic spread in 25% of cases and these patients will have limited benefit from surgery. Identification of...
Autores principales: | Laurberg, Jens Reumert, Jensen, Jørgen Bjerggaard, Schepeler, Troels, Borre, Michael, Ørntoft, Torben F, Dyrskjøt, Lars |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4164753/ https://www.ncbi.nlm.nih.gov/pubmed/25175477 http://dx.doi.org/10.1186/1471-2407-14-638 |
Ejemplares similares
-
Comprehensive multiregional analysis of molecular heterogeneity in bladder cancer
por: Thomsen, Mathilde Borg Houlberg, et al.
Publicado: (2017) -
miRNAs associated with chemo-sensitivity in cell lines and in advanced bladder cancer
por: Nordentoft, Iver, et al.
Publicado: (2012) -
Diagnosis of Bladder Cancer Recurrence Based on Urinary Levels of EOMES, HOXA9, POU4F2, TWIST1, VIM, and ZNF154 Hypermethylation
por: Reinert, Thomas, et al.
Publicado: (2012) -
Bioinformatic identification of FGF, p38-MAPK, and calcium signalling pathways associated with carcinoma in situ in the urinary bladder
por: Herbsleb, Malene, et al.
Publicado: (2008) -
Chromosomal imbalance in the progression of high-risk non-muscle invasive bladder cancer
por: Zieger, Karsten, et al.
Publicado: (2009)